<DOC>
	<DOCNO>NCT00323687</DOCNO>
	<brief_summary>There unmet medical need potent ART regimen make adherence treatment even easy due QD dosing , offer good tolerability profile fit daily life patient .</brief_summary>
	<brief_title>SONETT : Switch Study Once Daily HIV Treatment Regimen With Truvada</brief_title>
	<detailed_description />
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<criteria>Adult patient ( 18 year age ) ethnic group without restricted legal competence capable follow study instruction HIV1 infection document confirmed positive HIV1 antibody test and/or positive PCR HIV1 RNA Stable ( interruption change regimen last 3 month ) AZTand 3TCcontaining regimen &gt; 3 month No document prior virologic failure ( virological failure define 2 consecutive measurement 4 week apart viral load HIVRNA &gt; 400 copies/mL ART ) CD4+ count &gt; 50 cells/µL Viral load &lt; 50 copies/mL Karnofsky performance status ≥ 80 % For woman childbearing potential , negative urine pregnancy test Screening visit Serum phosphate level &lt; 0.65 mmol/L Documented active opportunistic infection Subjects previously document K65R , 69S mutation 3 thymidine analogue mutation Documented active malignant disease ( exclude Kaposi sarcoma limit skin ) Female childbearing potential willing use barrier method contraception heterosexual intercourse duration study Women pregnant breast feed Known history drug , medication alcohol abuse within last 12 month precede study Simultaneous participation another study investigational drug within less one month prior study Inability willing meet requirement protocol History seizure , central nervous system disorder psychiatric disability think clinically significant opinion investigator Limited mental capacity extent he/she provide inform consent information regard adverse event study medication Renal disease ( creatinine clearance &lt; 50 ml/min accord Cockroft_Gault formula ) severe hepatic , respiratory cardiovascular disease Patients previously enrol study Contraindication one study substance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>HIV-1 Infection</keyword>
</DOC>